Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$95.70

-0.35 (-0.36%)

04:55
01/12/18
01/12
04:55
01/12/18
04:55

Puma Biotechnology says CHMP to discuss neratinib on January 23

Puma Biotechnology announced last night that it met with Europe's Committee for Medicinal Products for Human Use Scientific Advisory Group on Oncology. SAG was asked to provide an opinion on the clinical relevance of the five-year absolute treatment difference in invasive disease free survival seen in the Phase III ExteNET trial and on the risk of gastrointestinal toxicity with neratinib and its acceptability in the proposed patient population in the company's Marketing Authorization Application for neratinib, Puma said. Based on the feedback from SAG and the rapporteurs, the company intends to modify the summary of product characteristics, sometimes referred to as the European product label, in its MAA for neratinib to further refine the intended population to patients at a high risk of disease recurrence. Puma noted that CHMP will be conducting an oral hearing to discuss the MAA for neratinib on January 23, and that it has been invited to present the risk benefit profile of neratinib in the identified population at this meeting.

PBYI Puma Biotechnology
$95.70

-0.35 (-0.36%)

11/10/17
FBCO
11/10/17
NO CHANGE
Target $142
FBCO
Outperform
Puma Biotechnology launch meeting high expectations, says Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Puma Biotechnology shares to $142 from $136 saying she believes the Nerlynx launch is living up to high expectations. The analyst keeps an Outperform rating on Puma following the Q3 results.
12/14/17
SBSH
12/14/17
NO CHANGE
Target $164
SBSH
Buy
Citi sees positive CHMP opinion for Puma's neratinib
Citi analyst Yigal Nochomovitz says his analysis of drugs evaluated during European Medicines Agency Scientific Advisory Group meetings in oncology provides "unusually strong evidence" that Puma Biotechnology's neratinib is likely to receive a positive Committee for Medicinal Products for Human Use opinion. Puma yesterday announced that the EMA requested a Scientific Advisory Group provide an opinion on the clinical aspects of neratinib on January 11, 2018. The analyst identified 14 instances where the EMA convened a SAG in oncology, with 86% receiving a positive CHMP opinion. Further, 100% of tyrosine kinase inhibitors in the examples Nochomovitz identified received a positive CHMP opinion. He believes this reinforces his positive view on neratinib. The analyst has a Buy rating on Puma Biotechnology with a $164 price target.
12/18/17
LEER
12/18/17
NO CHANGE
LEER
Puma Biotechnology, Clovis top picks in biotech for 2018 at Leerink
Leerink analyst Michael Schmidt expects oncology to remain an attractive area within Biotech in 2018. Key product launches, a rich set of pivotal trial results, and pending regulatory decisions among stocks he covers make 2018 a catalyst-rich year, particularly in the first half of 2018, the analyst contends. Puma Biotechnology (PBYI) and Clovis (CLVS) are Schmidt's top-picks with Incyte (INCY) as a close third. Additionally, he sees ImmunoGen (IMGN) and Karyopharm (KPTI) as attractive emerging small-caps for 2018.
01/03/18
SBSH
01/03/18
NO CHANGE
Target $164
SBSH
Buy
Puma Biotechnology sold off on FDA database comments, says Citi
Citi analyst Yigal Nochomovitz attributes the 5% pullback yesterday in shares of Puma Biotechnology to a competing research firm highlighting that the FDA's Adverse Event Reporting System shows 137 adverse events and four deaths among patients receiving Nerlynx. The FAERS has "substantial limitations which FDA has publically acknowledged," Nochomovitz tells investors in a research note titled "Alert: Word to the Wise on Using FDA's Adverse Event Reporting." The analyst believes the FAERS data by themselves are not an indicator of the safety profile of a drug. He keeps a Buy rating on Puma with a $164 price target.

TODAY'S FREE FLY STORIES

ANDX

Andeavor Logistics

$52.52

0.12 (0.23%)

16:31
01/19/18
01/19
16:31
01/19/18
16:31
Hot Stocks
Andeavor Logistics raises quarterly cash distribution to $1.00 per unit »

The fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

16:30
01/19/18
01/19
16:30
01/19/18
16:30
Options
Preliminary option volume of 22.8M today »

Preliminary option volume…

TRNC

tronc

$19.53

0.3 (1.56%)

16:26
01/19/18
01/19
16:26
01/19/18
16:26
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, DJ says »

Dow Jones added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$0.27

0.0285 (11.88%)

16:25
01/19/18
01/19
16:25
01/19/18
16:25
Conference/Events
Arcadia Biosciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FB

Facebook

$181.29

1.49 (0.83%)

16:23
01/19/18
01/19
16:23
01/19/18
16:23
Hot Stocks
Facebook provides update on trusted sources initiative »

Starting next week,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

MS

Morgan Stanley

$57.46

1.62 (2.90%)

, APO

Apollo Global

$34.74

-0.33 (-0.94%)

16:21
01/19/18
01/19
16:21
01/19/18
16:21
Hot Stocks
Morgan Stanley reports 5% passive stake in Apollo Global »

In a regulatory filing,…

MS

Morgan Stanley

$57.46

1.62 (2.90%)

APO

Apollo Global

$34.74

-0.33 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 01

    Feb

HBNC

Horizon Bancorp

$28.49

0.37 (1.32%)

16:19
01/19/18
01/19
16:19
01/19/18
16:19
Syndicate
Breaking Syndicate news story on Horizon Bancorp »

Horizon Bancorp files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:18
01/19/18
01/19
16:18
01/19/18
16:18
Hot Stocks
Breaking Hot Stocks news story on Sanmina »

Sanmina down 15% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Hot Stocks
Sanmina adopts consolidated restructuring plan »

On January 12, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$162.37

-6.75 (-3.99%)

, AXP

American Express

$98.03

-1.83 (-1.83%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
General news
On The Fly: Top stock stories for Friday »

Stocks were mixed for…

IBM

IBM

$162.37

-6.75 (-3.99%)

AXP

American Express

$98.03

-1.83 (-1.83%)

GE

General Electric

$16.26

-0.51 (-3.04%)

FB

Facebook

$181.29

1.49 (0.83%)

NCNA

NuCana

$20.51

6.02 (41.55%)

ACOR

Acorda Therapeutics

$27.20

2.2 (8.80%)

BIIB

Biogen

$342.41

-2.03 (-0.59%)

IPHI

Inphi

$32.07

-3.33 (-9.41%)

MKC

McCormick

$99.19

-3.72 (-3.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

  • 08

    Mar

$NSD

NASDAQ Market Internals

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/19/18
01/19
16:16
01/19/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$7.11

-0.24 (-3.27%)

, CVS

CVS Health

$79.85

0.5 (0.63%)

16:15
01/19/18
01/19
16:15
01/19/18
16:15
Periodicals
Delaware files lawsuit against opioid manufacturers, distributors, Reuters says »

Delaware has become the…

ENDP

Endo

$7.11

-0.24 (-3.27%)

CVS

CVS Health

$79.85

0.5 (0.63%)

WBA

Walgreens Boots Alliance

$76.47

0.47 (0.62%)

MCK

McKesson

$170.33

-1.45 (-0.84%)

CAH

Cardinal Health

$71.90

0.19 (0.26%)

ABC

AmerisourceBergen

$100.01

-0.85 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

ITI

Iteris

$7.49

0.03 (0.40%)

16:12
01/19/18
01/19
16:12
01/19/18
16:12
Hot Stocks
Neil Subin sells $748K in Iteris shares »

Neil Subin, a beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SANM

Sanmina

$35.45

0.5 (1.43%)

16:11
01/19/18
01/19
16:11
01/19/18
16:11
Earnings
Sanmina sees Q2 adjusted EPS 40c-50c, consensus 70c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:09
01/19/18
01/19
16:09
01/19/18
16:09
Earnings
Sanmina reports Q1 preliminary adjusted EPS 48c, consensus 71c »

Reports Q1 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.26

-0.74 (-0.22%)

16:07
01/19/18
01/19
16:07
01/19/18
16:07
Periodicals
Breaking Periodicals news story on Lockheed Martin »

U.S. approves sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

CPLA

Capella Education

$80.50

0.7 (0.88%)

, STRA

Strayer

$93.08

0.9 (0.98%)

16:06
01/19/18
01/19
16:06
01/19/18
16:06
Hot Stocks
Capella Education shareholders approve proposed merger with Strayer »

Capella Education (CPLA)…

CPLA

Capella Education

$80.50

0.7 (0.88%)

STRA

Strayer

$93.08

0.9 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 19

    Jan

ADM

Archer Daniels

$40.61

0.13 (0.32%)

, BG

Bunge

$69.78

0.14 (0.20%)

16:03
01/19/18
01/19
16:03
01/19/18
16:03
Periodicals
Archer Daniels made takeover approach to Bunge, WSJ says »

Archer Daniels Midland…

ADM

Archer Daniels

$40.61

0.13 (0.32%)

BG

Bunge

$69.78

0.14 (0.20%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

C

Citi

$78.16

0.77 (0.99%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

GOLF

Acushnet Holdings

$21.50

0.65 (3.12%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Hot Stocks
Acushnet Holdings acquires Linkgs & Kings, terms not disclosed »

Acushnet Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$69.79

0.145 (0.21%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:58
01/19/18
01/19
15:58
01/19/18
15:58
Hot Stocks
Breaking Hot Stocks news story on Bunge, Archer Daniels »

Bunge jumps 10% after…

BG

Bunge

$69.79

0.145 (0.21%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

BG

Bunge

$69.76

0.12 (0.17%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Periodicals
Breaking Periodicals news story on Bunge, Archer Daniels »

Archer Daniels made…

BG

Bunge

$69.76

0.12 (0.17%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

HGT

Hugoton Royalty Trust

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.85

0.17 (0.41%)

15:50
01/19/18
01/19
15:50
01/19/18
15:50
Options
Bullish option play in Comcast ahead of earnings next week »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.